[go: up one dir, main page]

DE60308450D1 - S-Omeprazol-Magnesiumsalz - Google Patents

S-Omeprazol-Magnesiumsalz

Info

Publication number
DE60308450D1
DE60308450D1 DE60308450T DE60308450T DE60308450D1 DE 60308450 D1 DE60308450 D1 DE 60308450D1 DE 60308450 T DE60308450 T DE 60308450T DE 60308450 T DE60308450 T DE 60308450T DE 60308450 D1 DE60308450 D1 DE 60308450D1
Authority
DE
Germany
Prior art keywords
magnesium salt
omeprazole
omeprazole magnesium
enantiomer
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308450T
Other languages
English (en)
Other versions
DE60308450T2 (de
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29555354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60308450(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60308450D1 publication Critical patent/DE60308450D1/de
Publication of DE60308450T2 publication Critical patent/DE60308450T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60308450T 2002-05-17 2003-05-16 S-Omeprazol-Magnesiumsalz Expired - Lifetime DE60308450T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2386716 2002-05-17
CA2386716A CA2386716C (en) 2002-05-17 2002-05-17 Magnesium salt of s-omeprazole

Publications (2)

Publication Number Publication Date
DE60308450D1 true DE60308450D1 (de) 2006-11-02
DE60308450T2 DE60308450T2 (de) 2007-05-10

Family

ID=29555354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308450T Expired - Lifetime DE60308450T2 (de) 2002-05-17 2003-05-16 S-Omeprazol-Magnesiumsalz

Country Status (5)

Country Link
EP (1) EP1375497B1 (de)
JP (1) JP2004002422A (de)
AT (1) ATE340170T1 (de)
CA (1) CA2386716C (de)
DE (1) DE60308450T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AU2003262992A1 (en) 2002-08-30 2004-03-19 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1801110A1 (de) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Argininsalz des Esomeprazols
EP1947099A1 (de) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
EP2147918A1 (de) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
CN116102538B (zh) * 2023-01-29 2024-10-18 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole

Also Published As

Publication number Publication date
ATE340170T1 (de) 2006-10-15
DE60308450T2 (de) 2007-05-10
EP1375497B1 (de) 2006-09-20
CA2386716C (en) 2012-07-24
EP1375497A1 (de) 2004-01-02
JP2004002422A (ja) 2004-01-08
CA2386716A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
JP2004506350A5 (de)
JP2006523595A5 (de)
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
DE60308450D1 (de) S-Omeprazol-Magnesiumsalz
DE602005002130D1 (de) Metallorganisches gerüstmaterial, herstellung und verwendung
ATE518821T1 (de) Verfahren zur herstellung von alkenonethern
IS7909A (is) Aðferð til að framleiða ljósfræðilega hrein virk efnasambönd
ATE433434T1 (de) Verfahren zur herstellung von menthol
ATE302744T1 (de) Verfahren zur herstellung von 1-menthol
DE602004019472D1 (de) Herstellungsverfahren von Membran-Elektroden-Einheiten
EP1721895A4 (de) Verfahren zur herstellung von cumenhydroperoxid
DE602004021052D1 (de) Herstellungsverfahren von Xylylendiamin
DE60323456D1 (de) Herstellung von Nanopartikeln
ATE388957T1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
ATE352549T1 (de) Verfahren zur herstellung von desloratadin
ATE369357T1 (de) Verfahren zur herstellung von pantoprazol und seinen salzen
DE60326321D1 (de) Herstellungsverfahren von Farbstoffen
ITMI20030150A1 (it) Processo per preparare fluoroalogenoeteri.
ATE513840T1 (de) Verfahren zur herstellung optisch aktiver diphosphane
ATE553101T1 (de) Herstellungsverfahren für 2-oxo-1-phenyl-3- oxabicycloä3.1.0ühexan
ATE412613T1 (de) Verfahren zur herstellung von aluminiumtrihydraten mit hohem porenvolumen
DE502006007059D1 (de) Racematspaltung von 2,6-trans-dimethylmorpholin
ITRM20010318A1 (it) Procedimento per la produzione di composti organici perfluorurati mediante florurazione elettrochimica.
ATE487701T1 (de) Verfahren zur herstellung von iminostilbenderivaten
CY1110479T1 (el) Μια μεθοδος δια την παρασκευη μιας 10,11- διυδρο- 10- υδροξυ - 5η-διβενζ [bf] αζεπινο- 5- καρβοξυαμιδης

Legal Events

Date Code Title Description
8363 Opposition against the patent